arrow
J

Johannes M. Giesinger

Medical University of Innsbruck
H指数:46
被引数:7,820

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From patient-reported outcome scores to clinical meaning: defining thresholds for clinical importance for the EORTC QLQ-PR25 questionnaire for patients with prostate cancer

从患者报告结局评分到临床意义:为前列腺癌患者EORTC QLQ-PR25问卷定义临床重要性的阈值

2026-10-100
OA
Single-item measures of perceived side effect burden for people with cancer: A systematic scoping review

癌症患者感知副作用负担的单项目测量:一项系统范围综述

2026-10-040
OA
Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer

报告辅助全身治疗随机临床试验中的健康相关生活质量:常识肿瘤学和欧洲癌症研究与治疗组织的建议

2026-09-290
PRE
Developing thresholds for clinical importance for the EORTC Quality of Life Questionnaire-Elderly 14 (QLQ-ELD14) to improve its interpretation in clinical practice and research

为EORTC生活质量问卷-老年14(QLQ-ELD14)制定临床重要性阈值,以改进其在临床实践和研究中的解释

2026-08-010
OAAI
A mixed methods study on patients' and healthcare professionals' understanding of the graphical presentation of patient-reported outcome data at an inpatient unit for psychosomatic medicine

对心身医学住院病区患者和医疗专业人员对图形化呈现的患者报告结局数据理解情况的混合方法研究

2026-04-110
OA
What’s missing in patient-reported outcome reporting? A scoping review and aggregated trial-level analysis of completion rates in oncology randomized controlled trials

患者报告结局报告的缺失是什么?一项范围综述和肿瘤学随机对照试验中完成率的聚合试验水平分析

2025-12-230
OAAI
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials

SISAQOL-IMI基于共识的指南:用于癌症临床试验中患者报告结局的设计、分析、解释与呈现

2025-11-240
PRE
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes

EORTC QLQ-C30总结评分在癌症研究中的应用及其与EORTC QLQ-C30总体健康/生活质量量表性能的比较:一项效应量的系统评价和比较分析

2025-10-260
OAAI
B THE USE OF EORTC QLQ-C30 SUMMARY SCORE IN CANCER CLINICAL TRIALS AND ITS PERFORMANCE AS COMPARED WITH THE GLOBAL HEALTH / QUALITY OF LIFE SCALE: A COMPARATIVE ANALYSIS OF EFFECT SIZES

B 癌症临床试验中EORTC QLQ-C30总结评分的应用及其与全球健康/生活质量量表性能的比较:效应量比较分析

2025-10-010
OA
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

在晚期癌症临床试验中报告与健康相关的生活质量数据时,应答者标准的重要性:常识肿瘤学与欧洲癌症研究与治疗组织的建议

2025-09-010
PRE
Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index

评估复发/难治性多发性骨髓瘤患者虚弱程度:患者报告的虚弱表型与国际骨髓瘤工作组虚弱指数的比较

2025-06-040
PRE
The EORTC QLQ-F17 as a shortened version of the EORTC QLQ-C30 to assess self-reported functioning in cancer patients: investigating equivalence and psychometric properties in a randomized cross-over trial

EORTC QLQ-F17 作为 EORTC QLQ-C30 的简短版本,用于评估癌症患者的自报功能:在一项随机交叉试验中探究其等价性和心理测量属性

2025-06-010
OA
Development and validation of crosswalks between the EORTC QLQ-C30 physical, role, social and emotional functioning, fatigue and global health status/quality of life scales and their corresponding PROMIS scales

EORTC QLQ-C30躯体功能、角色功能、社会功能、情绪功能、疲劳和总体健康状态/生活质量量表及其对应的PROMIS量表的交叉walks的开发与验证

2025-05-290
OA